Aurobindo Pharma (AUROPHARMA) Share Price Falls 2.47% to Rs 1,661
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Aurobindo Pharma Share Price was under pressure in the latest session, with Aurobindo Pharma Share Price trading at Rs 1,661, down 2.47% from the previous close of Rs 1,703. The company’s market capitalisation stood at Rs 97,814.24 crore, keeping Aurobindo Pharma Share Price in Large Cap territory. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Aurobindo Pharma Share Price Today, the move matters because it combines a clear intraday decline with a sizeable market value and a valuation profile that can be compared against the healthcare peer set.
In Aurobindo Pharma Share Price terms, the stock opened at Rs 1,694.75, touched a high of Rs 1,706.10 and a low of Rs 1,649.35. That range shows Aurobindo Pharma Share Price moving below the previous close during the session and remaining near the lower end of the day’s band as of 30 September 2026 at 10:53:17 AM IST. Univest continues to track Aurobindo Pharma Share Price as part of its live stock coverage for investors looking at price action, fundamental analysis and sector comparison in one place.
Aurobindo Pharma (AUROPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,661 |
| Previous Close | Rs 1,703 |
| Today's Move | -Rs 42.00 (-2.47%) |
| Open | Rs 1,694.75 |
| High | Rs 1,706.1 |
| Low | Rs 1,649.35 |
| Market Capitalisation | Rs 97,814.24 crore |
| Market Cap Category | Large Cap |
Aurobindo Pharma Share Price Today reflects a decline of Rs 42 from the previous close, which is a 2.47% fall from Rs 1,703 to Rs 1,661. The stock opened slightly below the previous close at Rs 1,694.75, moved to an intraday high of Rs 1,706.10 and then touched a low of Rs 1,649.35. That means Aurobindo Pharma Share Price spent the session trading inside a relatively tight range compared with the full move from open to low. The market capitalisation of Rs 97,814.24 crore places Aurobindo Pharma Share Price in the Large Cap category, so even a modest percentage move translates into a meaningful change in equity value. For investors following Aurobindo Pharma Share Price Live, the key point is the verified decline itself; according to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the next step a closer look at the valuation and business ratios that frame Aurobindo Pharma Share Price today.
Aurobindo Pharma (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 97,814.24 crore |
| P/E Ratio | 26.39x |
| P/B Ratio | 2.52x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.23% |
Aurobindo Pharma Share Price can be read more clearly through its fundamentals. The stock trades at a P/E ratio of 26.39 and a P/B ratio of 2.52, while enterprise value is not part of the visible figures used here. For Aurobindo Pharma Share Price, EPS stands at Rs 64.52, book value is Rs 676.49 per share and dividend yield is 0.23%. EPS shows earnings attributable to each share, book value per share shows the accounting net worth behind each share, and dividend yield shows the historical payout relative to the current price. ROE is 9.93% and ROCE is 12.76%, which gives Aurobindo Pharma Share Price a moderate return profile rather than one that is visibly stretched on profitability metrics alone. These numbers do not explain the day’s fall on their own, but they do help investors place Aurobindo Pharma Share Price within a valuation framework. In Univest research terms, the stock is moving with a mix of reasonable asset backing and mid-range return ratios, which is useful context before moving to the healthcare sector benchmark.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.39x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 2.52x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 97,814.24 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Aurobindo Pharma Share Price sits in the Healthcare sector and the Pharmaceuticals & Drugs industry, where valuation and return ratios differ sharply across the same industry benchmark. The benchmark scope covers 199 companies in the same industry. Against that set, Aurobindo Pharma Share Price has a P/E of 26.39 versus a median of 32.43 and an average of 49.46, so its earnings multiple is below both reference points. Its P/B of 2.52 is also below the industry median of 2.89 and the average of 4.38. ROE at 9.93% is below the benchmark median of 11.70% and the average of 10.68%, while ROCE at 12.76% is slightly below the median of 13.61% and the average of 13.40%. In market capitalisation terms, Aurobindo Pharma Share Price at Rs 97,814.24 crore is far above the industry median of Rs 776.09 crore and also above the benchmark average of Rs 14,255.40 crore. That combination suggests a large, established healthcare name trading at lower multiples than many industry peers. Univest data therefore places Aurobindo Pharma Share Price in a context where the day’s decline sits alongside a valuation that is not elevated versus the broader pharmaceuticals peer set.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Aurobindo Pharma Share Price looks more measured on valuation than several major healthcare peers in the comparison set. Its P/E of 26.39 is below Sun Pharmaceutical Industries at 36.90, well below Divi’s Laboratories at 85.99, and beneath Torrent Pharmaceuticals at 85.72. It is also close to Zydus Lifesciences at 26.42, while Cipla is slightly higher at 33.15. On P/B, Aurobindo Pharma Share Price at 2.52 is below all five listed peers shown here. On ROE, its 9.93% trails each peer in this set, while ROCE at 12.76% is also below the peer figures displayed. In market capitalisation, Aurobindo Pharma Share Price at Rs 97,814.24 crore is larger than Zydus Lifesciences, Cipla and Dr. Reddy’s Laboratories, but smaller than Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals These comparisons help readers place Aurobindo Pharma Share Price within the healthcare pack without stretching beyond the numbers.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price fell 2.47% in the latest session, so the day’s move is clear and measurable.
- Aurobindo Pharma Share Price Today sits at Rs 1,661, after moving between Rs 1,649.35 and Rs 1,706.10.
- Aurobindo Pharma Share Price is backed by a market capitalisation of Rs 97,814.24 crore, which keeps it in the Large Cap category.
- Aurobindo Pharma Share Price trades at a P/E of 26.39 and a P/B of 2.52, both below several peer readings.
- Aurobindo Pharma Share Price has ROE of 9.93% and ROCE of 12.76%, which investors may compare with the healthcare benchmark.
About Aurobindo Pharma
Aurobindo Pharma operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Aurobindo Pharma Share Price therefore reflects a business that is part of one of India’s most closely watched healthcare groups. The company’s market position is framed by its Large Cap size, Rs 97,814.24 crore market capitalisation and its presence among the listed peers used in Univest analysis. Readers tracking Aurobindo Pharma Stock News often focus on how its valuation, returns and sector positioning compare with other drug makers. The company’s share profile is therefore not just about today’s decline; it is also about where Aurobindo Pharma Share Price sits within the broader pharmaceuticals landscape, especially when viewed alongside industry benchmark ratios and peer market capitalisation figures.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma (AUROPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Aurobindo Pharma Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights. The platform also helps readers follow Aurobindo Pharma Share Price Today alongside sector context, peer comparison and company-level fundamentals. If you are checking Aurobindo Pharma Stock Analysis or Aurobindo Pharma Latest News, Univest brings the relevant numbers together in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Aurobindo Pharma Share Price falling today?
Ans. Aurobindo Pharma Share Price fell 2.47% to Rs 1,661 from Rs 1,703. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for the move.
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price today is Rs 1,661. The stock opened at Rs 1,694.75, touched Rs 1,706.10 and moved to a low of Rs 1,649.35 during the session. The previous close was Rs 1,703.
What is Aurobindo Pharma market capitalisation?
Ans. Aurobindo Pharma Share Price corresponds to a market capitalisation of Rs 97,814.24 crore. That places the company in the Large Cap category and well above the industry median in the benchmark set.
How does Aurobindo Pharma compare with healthcare peers?
Ans. Aurobindo Pharma Share Price trades at a lower P/B than all five listed peers shown here and a lower P/E than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. Its ROE and ROCE are also below the peer set.
What is Aurobindo Pharma Share Price valuation?
Ans. Aurobindo Pharma Share Price has a P/E of 26.39 and a P/B of 2.52. Those levels sit below the industry median and average, while ROE and ROCE remain below the benchmark median.
What does Aurobindo Pharma EPS show?
Ans. Aurobindo Pharma Share Price is supported by EPS of Rs 64.52. EPS indicates earnings attributable to each share, giving investors a useful context when comparing price with profitability and valuation.
What is Aurobindo Pharma book value per share?
Ans. Aurobindo Pharma Share Price has a book value of Rs 676.49 per share. Book value per share shows accounting net worth behind each share and helps frame the stock’s valuation relative to assets.
Should investors track Aurobindo Pharma Share Price on Univest?
Ans. Yes, investors tracking Aurobindo Pharma Share Price can use Univest for live updates, valuation ratios, sector comparison and company context. It is useful for following price action alongside peer and industry benchmarks.
